Does CLONAZEPAM Cause Interstitial lung disease? 13 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Interstitial lung disease have been filed in association with CLONAZEPAM (Clonazepam). This represents 0.0% of all adverse event reports for CLONAZEPAM.
13
Reports of Interstitial lung disease with CLONAZEPAM
0.0%
of all CLONAZEPAM reports
2
Deaths
6
Hospitalizations
How Dangerous Is Interstitial lung disease From CLONAZEPAM?
Of the 13 reports, 2 (15.4%) resulted in death, 6 (46.2%) required hospitalization.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CLONAZEPAM. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does CLONAZEPAM Cause?
Drug ineffective (5,088)
Toxicity to various agents (4,028)
Completed suicide (3,320)
Drug abuse (3,287)
Off label use (2,590)
Anxiety (2,376)
Somnolence (2,260)
Dyspnoea (1,987)
Depression (1,838)
Insomnia (1,836)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which CLONAZEPAM Alternatives Have Lower Interstitial lung disease Risk?
CLONAZEPAM vs CLONIDINE
CLONAZEPAM vs CLOPIDOGREL
CLONAZEPAM vs CLOPIDOGREL BESILATE
CLONAZEPAM vs CLOPIDOGREL BISULFATE
CLONAZEPAM vs CLORAZEPATE